New Delhi: After the expert panel of the drug regulator granted approval for the emergency use authorisation of Oxford AstraZeneca’s Covishield and Bharat Biotech’s Covaxin COVID-19 vaccines .

The Director of All India Institute of Medical Sciences (AIIMS) Dr. Randeep Guleria on Saturday told News 18 that India was ready for a mass rollout of the COVID-19 vaccine in the next 10 to 14 days. 

“We will start the vaccination in a slow process. By that time more vaccines will be available,” he said.

Guleria stressed on the need for a proper time table to ensure crowd management when the vaccination process commences.

The he Subject Expert Committee of CDSCO had on Friday recommended emergency use authorisation of the AstraZeneca-Oxford vaccine and the Drugs Control Authority of India approval is expected on Sunday, January 3, 2021.

On Saturday the expert panel recommended that Bharat Biotech Covid-19 vaccine applicant Covaxin be approved for restricted emergency use in India

Meanwhile, a dry run for the vaccination against COVID-19 was held across all states on Saturday in order to ensure smooth inoculation of the country’s population when the shots are rolled out.

Meanwhile, dry run for COVID-19 vaccination commenced in all States and UT governments across the country from Saturday with the objective to gear up for the roll-out of COVID-19 vaccine when it is ready. 

According to Union Health Ministry, the objective is to “assess operational feasibility in the use of COVID Vaccine Intelligence Network (Co-WIN) application in a field environment, to test the linkages between planning and implementation and to identify the challenges and guide the way forward prior to actual implementation”. 

Source link


Please enter your comment!
Please enter your name here